Indication
Chronic Myeloid Leukemia in Myeloid Blast Crisis
1 clinical trial
1 product
Clinical trial
Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT) Recipients With Hematologic Malignancies (HM)Status: Recruiting, Estimated PCD: 2026-09-01
Product
Orca-Q